Clinical trial
Detecting the Undetected: an Observational Cohort Study Evaluating the Health Economics, Clinical Utility, and Patient and Staff Experiences of Innovative Peptide Testing to Screen for Heart Failure in Lymphoedema Clinics
NCT07498868 is registered in ClinicalTrials.gov with Swansea Bay University Health Board as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detecting the Undetected: an Observational Cohort Study Evaluating the Health Economics, Clinical Utility, and Patient and Staff Experiences of Innovative Peptide Testing to Screen for Heart Failure in Lymphoedema Clinics
- Lead sponsor
- Swansea Bay University Health Board
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- September 30, 2028
- Enrollment
- 618 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, heart failure (for example, fluid overload), heart failure (hf), lymphedema, lymphedema, lower limb